Seven patents currently held, every record listed here
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in May 2036. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
May 2036
Next term end
3
Patent families
When these terms end
Each bar runs from grant to computed term end. 2020 to 2043.
US 11,135,369
Measurement of Glucose in an Insulin Delivery Catheter by Minimizing the Adverse Effects of Insulin Preservatives
Jul 13, 2036
US 10,780,222
Measurement of Glucose in an Insulin Delivery Catheter by Minimizing the Adverse Effects of Insulin Preservatives
Oct 26, 2037
US 12,495,995
Measurement of Glucose Near an Insulin Delivery Catheter by Minimizing the Adverse Effects of Insulin Preservatives: Alternative Ligands and Redox Mediator Metals
Aug 20, 2041
US 12,216,074
Biosensors and Methods for Determining Analyte Concentration in the Kinetic Potential Region of Redox Mediators
Mar 14, 2043
20252030203520402043
11 pending applications: term is not computable until grant.Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Only 2 of the currently held patents qualify as notable.
Notable
Ends Oct 2037 · High confidence
Also notable
Ends Aug 2041 · High confidence
Measurement of Glucose in an Insulin Delivery Catheter by Minimizing the Adverse Effects of Insulin Preservatives
US 10,780,222
The most cited patent in this portfolio, cited by 19 later US patents, top 10% of utility patents granted in 2020 in our data. Protection runs to 2037.
Measurement of Glucose Near an Insulin Delivery Catheter by Minimizing the Adverse Effects of Insulin Preservatives: Alternative Ligands and Redox Mediator Metals
US 12,495,995
Granted 2025. Too new for citation comparison; protection runs to 2041.
Fee deadlines
No maintenance fee falls due on this company's record before Nov 16, 2027.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
What they patent
Grouped by real patent family, largest first, labeled by the earliest filing in each. No technology classification is inferred from titles.
Patents held now
Soonest term end first.
Showing 1 to 7 of 7
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 12,383,675 | Methods and Systems for Insulin Delivery and Glucose Measurement In force · Medium confidence | In force | Medium confidence | |
| US 12,478,734 | Methods and Systems for Insulin Delivery and Glucose Measurement In force · High confidence | In force | High confidence | |
| US 12,611,504 | Methods and Systems for Insulin Delivery and Glucose Measurement In force · Medium confidence | In force | Medium confidence | |
| US 11,135,369 | Measurement of Glucose in an Insulin Delivery Catheter by Minimizing the Adverse Effects of Insulin Preservatives In force · High confidence | In force | High confidence | |
| US 10,780,222 | Measurement of Glucose in an Insulin Delivery Catheter by Minimizing the Adverse Effects of Insulin Preservatives In force · High confidence | In force | High confidence | |
| US 12,495,995 | Measurement of Glucose Near an Insulin Delivery Catheter by Minimizing the Adverse Effects of Insulin Preservatives: Alternative Ligands and Redox Mediator Metals In force · High confidence | In force | High confidence | |
| US 12,216,074 | Biosensors and Methods for Determining Analyte Concentration in the Kinetic Potential Region of Redox Mediators In force · High confidence | In force | High confidence |
Also on record, not counted in the 7: 11 applications pending · 2 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
2 computed term dates come from a chain with an unresolved parent. A continuity parent has not yet been fetched from USPTO's records. The term is dated from this application's own claim; no earlier date is assumed until the parent is resolved.